TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
Company voluntarily withdraws UKONIQ® from sale for approved indications of relapsed/refractory MZL and FL Company to host conference call, Monday, April 18, 2022 at 8:30 AM ET NEW YORK, April 15, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 15, 2022 Category: Pharmaceuticals Source Type: clinical trials
Recruitment of young adult cancer survivors into a randomized controlled trial of an mHealth physical activity intervention
ConclusionsThe IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS.Trial registrationClinicalTrials.govNCT03569605. Registered on 26 June 2018. (Source: Trials)
Source: Trials - April 4, 2022 Category: Research Source Type: clinical trials
Randomized Evaluation of Surgery in Elderly with Traumatic Acute SubDural Hematoma (RESET-ASDH trial): study protocol for a pragmatic randomized controlled trial with multicenter parallel group design
DiscussionThe study results will be implemented after publication and presented on international conferences. Depending on the trial results, the current Brain Trauma Foundation guidelines will either be substantiated by high-quality evidence or will have to be altered.Trial registrationNederlands Trial Register (NTR), TrialNL9012. ClinicalTrials.gov, TrialNCT04648436. (Source: Trials)
Source: Trials - March 29, 2022 Category: Research Source Type: clinical trials
Standardization of Non-academic Center Surgical Morbidity and Mortality Conference: a Type I Hybrid Implementation Non-clinical Trial.
Conditions: Surgery; Surgery--Complications Intervention: Behavioral: Morbidity and mortality conference toolkit Sponsor: Poudre Valley Health System Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials
